A newly designed peptide shows promise in preventing the misfolding of alpha-synuclein, the protein implicated in Parkinson’s disease and certain dementias. Lab and animal studies indicate the peptide stabilizes the protein and enhances motor skills, highlighting the potential of rational drug design for previously untreatable brain disorders.
find the original post here https://www.sciencedaily.com/releases/2025/10/251008030949.htm
Leave a Reply